Mycophenolate-mofetil in the treatment of refractory multiple sclerosis

@article{Ahrens2001MycophenolatemofetilIT,
  title={Mycophenolate-mofetil in the treatment of refractory multiple sclerosis},
  author={N. Ahrens and A. Salama and J. Haas},
  journal={Journal of Neurology},
  year={2001},
  volume={248},
  pages={713-714}
}
Sirs: Multiple sclerosis (MS) is thought to be an autoimmune disease stimulated by activated lymphocytes, and the entry of T and B cells into the central nervous system [1]. Despite the use of a variety of immunomodulatory and immunosuppressive agents including interferon beta, glatiramer acetate, intravenous immunoglobulins, azathioprine and escalating chemotherapy with mitoxantrone and cyclophosphamide, MS remains progressive in a large number of patients and there is an ongoing need for… Expand
Mycophenolate Mofetil in Multiple Sclerosis
Immunosuppressive treatments in multiple sclerosis.
  • D. Okuda
  • Medicine
  • Handbook of clinical neurology
  • 2014
Role of Immunosuppressive Therapy for the Treatment of Multiple Sclerosis
Mycophenolate mofetil in multiple sclerosis: a multicentre retrospective study on 344 patients
Immunosuppressive agents in multiple sclerosis
Mycophenolate mofetil in combination with interferon beta-1a in the treatment of relapsing-remitting multiple sclerosis: A preliminary study
  • M. Etemadifar, M. Kazemi, +4 authors A. Maghzi
  • Medicine
  • Journal of research in medical sciences : the official journal of Isfahan University of Medical Sciences
  • 2011
...
1
2
3
4
5
...

References

SHOWING 1-4 OF 4 REFERENCES
Treatment of multiple sclerosis: recent trials and future perspectives.
Immunomodulating therapeutic approaches for multiple sclerosis
Immunologic aspects of multiple sclerosis.